Caricamento...

Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Administration of Verinurad and Febuxostat in Healthy Male Volunteers

Verinurad (RDEA3170) is a selective uric acid reabsorption inhibitor in development for treatment of gout and asymptomatic hyperuricemia. This phase 1, single‐blind, multiple‐dose, drug‐drug interaction study evaluated the pharmacokinetics (PK), pharmacodynamics, and safety/tolerability of verinurad...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Pharmacol Drug Dev
Autori principali: Hall, Jesse, Gillen, Michael, Yang, Xiaojuan, Shen, Zancong
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6586034/
https://ncbi.nlm.nih.gov/pubmed/29688628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.463
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !